Search by Drug Name or NDC

NDC 53002-1437-03 Tizanidine 4 mg/1 Details

Tizanidine 4 mg/1

Tizanidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is TIZANIDINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Tizanidine is used to relieve the spasms and increased muscle tone caused by multiple sclerosis (MS, a disease in which the nerves do not function properly and patients may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control), stroke, or brain or spinal injury. Tizanidine is in a class of medications called skeletal muscle relaxants. It works by slowing action in the brain and nervous system to allow the muscles to relax.

Related Packages: 53002-1437-03
Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Tizanidine

Product Information

NDC	53002-1437
Product ID	53002-1437_e973fec0-fdba-41eb-a143-0f50cdbe65ef
Associated GPIs	75100090100320
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Tizanidine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tizanidine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	4
Active Ingredient Units	mg/1
Substance Name	TIZANIDINE HYDROCHLORIDE
Labeler Name	RPK Pharmaceuticals, Inc.
Pharmaceutical Class	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA091283
Listing Certified Through	2024-12-31

Package

NDC 53002-1437-03 (53002143703)

Pricing Information	N/A
NDC Package Code	53002-1437-3
Billing NDC	53002143703
Package	30 TABLET in 1 BOTTLE (53002-1437-3)
Marketing Start Date	2022-01-01
NDC Exclude Flag	N